Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer displays an updated ClinicalTrials.gov revision number, changing from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T03:55:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added describing a transition from the term “artificial intelligence” to “super intelligence” and linking to updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-25T04:51:19.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T04:33:13.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:18:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The Records History now includes a new Revision: v3.7.0 and removes the previous Revision: v3.6.6, updating the history with the latest version label.
    Difference
    0.1%
    Check dated 2026-09-20T02:31:56.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The record history adds a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), signaling an update to the study record's documentation.
    Difference
    0.1%
    Check dated 2026-08-30T00:23:42.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.